About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Massachusetts General Hospital Cancer Center
https://www.massgeneral.org/cancer-center
Changing Updates in Hematologic Malignancies
Grand Rounds
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Maintenance Therapy in AML: Protecting Remission, Extending Survival, and Preventing Early Relapse
By
Massachusetts General Hospital Cancer Center
FEATURING
Andrew Brunner
By
Massachusetts General Hospital Cancer Center
FEATURING
Andrew Brunner
208 views
February 2, 2023
0 Comments
Login to view comments.
Click here to Login
Videos
11:21
Massachusetts General Hospital Cancer Center
Uveal Melanoma for Community Oncologists
Feat.
K. Montazeri
14:06
Insights from 2023 Society for Melanoma Research Annual Meeting
2023 SMR Congress Insights: "Time-to-Event Machine Learning Pre…
Feat.
Y. Semenov
18:31
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CAR/BsAb Toxicity in MM - Prevention, Treatment, and Surv…
Feat.
N. S. Raje
10:42
Insights from 2023 EHA® Annual Meeting
Updated Data for Ziftomenib in Adults With NPM1-Mutated R/R AML
Feat.
A. Fathi
06:25
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Phase 1/2 TRIDENT-1 Trial - Intracranial …
Feat.
J. Lin
16:49
Massachusetts General Hospital Cancer Center
ESR1 Mutations in HR+/HER2- mBC and Their Role in Treatment Outcomes
Feat.
S. Wander
17:54
Massachusetts General Hospital Cancer Center
Genetic Heterogeneity in Brain Metastases and Implications for Clini…
Feat.
P. Brastianos
09:52
Massachusetts General Hospital Cancer Center
Maintenance Therapy in AML: Protecting Remission, Extending Survival…
Feat.
A. Brunner
08:20
Massachusetts General Hospital Cancer Center
ESMO 2021 Updates on 1L DKN-01 + Tislelizumab & Chemotherapy in …
Feat.
S. Klempner
12:08
Massachusetts General Hospital Cancer Center
Selpercatinib Efficacy & Safety in Patients With RET-Altered Thy…
Feat.
L. Wirth
10:05
i3 Health
Emerging Treatment Strategies for Advanced Cholangiocarcinoma: Molec…
Feat.
L. Goyal
50:37
Massachusetts General Hospital Cancer Center
Next Steps in FGFRi in Cholangiocarcinoma: FGFR Pathway & Curren…
Feat.
L. Goyal
04:27
Massachusetts General Hospital Cancer Center
ASCO 2021 Highlights From GEOMETRY mono-1 Study on Advanced NSCLC: C…
Feat.
R. Heist
16:46
Virtual West Oncology Conference
2021 Updates on mTNBC: Do Olaparib/Talazoparib Improve PFS Compared …
Feat.
N. Vidula
18:15
CancerGRACE
Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon …
Feat.
Z. Piotrowska
10:33
GRACE
Targeted Therapy for EGFR+ NSCLC: How Do We Think About Acquired Res…
Feat.
Z. Piotrowska
31:44
Massachusetts General Hospital Cancer Center
Tumor Infiltrating Lymphocytes: What Is the Data That Supports the P…
Feat.
K. Flaherty
13:52
2020 ASCO Virtual Direct™ Highlights
Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dx…
Feat.
I. Dagogo-Jack
05:44
2020 Virtual ESMO Review
2020 ESMO Update on Targeted Therapy in NSCLC: Can We Safely Combine…
Feat.
I. Dagogo-Jack
07:33
2020 Virtual ESMO Review
2020 ESMO Update on Targeted Therapy in NSCLC: Does ADAURA Trial Sug…
Feat.
I. Dagogo-Jack
07:14
ecancer
2020 ESMO Update on ADCs in mTNBC: Is Sacituzumab Govitecan More Ben…
Feat.
A. Bardia
13:34
2020 Virtual ESMO Review
2020 ESMO Update on Targeted Therapy in NSCLC: Can We Safely Combine…
Feat.
I. Dagogo-Jack
26:39
Virtual Diversity in Cancer Care
Risk Factors in Lung Cancer: Which Risk Factor Is Predominant? How I…
Feat.
I. Dagogo-Jack